THC/CBD Pharma Clinical Trials: Financial Model

Company Description: 

DGX, a UK-based pharma startup, is pioneering THC and CBD-based treatments for endometriosis, menstrual pain, and chronic pain relief.  

The Challenge: 

With groundbreaking drugs in the pipeline, DGX aimed to raise funds for clinical trials in the UK and US. They needed a financial model to map cash flow, forecast trial-phase revenue, and determine total funding needs.  

The Solution:

We created a vertical financial model, breaking down each business unit by development stage and market expansion. The model delivered a clear funding roadmap, strengthening DGX’s pitch.